Currently, common molecular markers associated with the prognosis of glioma include IDH, MGMT, telomerase reverse transcriptase (TERT), the short arm of chromosome 1 and the long arm of chromosome 19 (1p/19q) (Ludwig & Kornblum, 2017). Here, MGMT is linked to central nervous system cancer.